Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-05-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/5/e057084.full |
| _version_ | 1811250168010375168 |
|---|---|
| author | Markos Marangos Anastasia Parthymou Evagelia E Habeos George I Habeos Apostolos Deligakis Ektoras Livieratos Dionysios V Chartoumpekis |
| author_facet | Markos Marangos Anastasia Parthymou Evagelia E Habeos George I Habeos Apostolos Deligakis Ektoras Livieratos Dionysios V Chartoumpekis |
| author_sort | Markos Marangos |
| collection | DOAJ |
| first_indexed | 2024-04-12T16:00:28Z |
| format | Article |
| id | doaj.art-681a92417ae74e838e5c9d1af05905f1 |
| institution | Directory Open Access Journal |
| issn | 2044-6055 |
| language | English |
| last_indexed | 2024-04-12T16:00:28Z |
| publishDate | 2022-05-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj.art-681a92417ae74e838e5c9d1af05905f12022-12-22T03:26:13ZengBMJ Publishing GroupBMJ Open2044-60552022-05-0112510.1136/bmjopen-2021-057084Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western GreeceMarkos Marangos0Anastasia Parthymou1Evagelia E Habeos2George I Habeos3Apostolos Deligakis4Ektoras Livieratos5Dionysios V Chartoumpekis61 Division of Hematology, Department of Internal Medicine, Medical School, University of Patras, Patras, GreeceDivision of Endocrinology, Department of Internal Medicine, University of Patras, Patras, GreeceDivision of Endocrinology, Department of Internal Medicine, University of Patras, Patras, GreeceDivision of Endocrinology, Department of Internal Medicine, University of Patras, Patras, GreeceGeneral Hospital of Patras St Andrews, Patras, GreeceDivision of Endocrinology, Department of Internal Medicine, University of Patras, Patras, GreeceDivision of Endocrinology, Department of Internal Medicine, University of Patras, Patras, Greecehttps://bmjopen.bmj.com/content/12/5/e057084.full |
| spellingShingle | Markos Marangos Anastasia Parthymou Evagelia E Habeos George I Habeos Apostolos Deligakis Ektoras Livieratos Dionysios V Chartoumpekis Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece BMJ Open |
| title | Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece |
| title_full | Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece |
| title_fullStr | Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece |
| title_full_unstemmed | Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece |
| title_short | Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece |
| title_sort | factors associated with anti sars cov 2 antibody titres 3 months post vaccination with the second dose of bnt162b2 vaccine a longitudinal observational cohort study in western greece |
| url | https://bmjopen.bmj.com/content/12/5/e057084.full |
| work_keys_str_mv | AT markosmarangos factorsassociatedwithantisarscov2antibodytitres3monthspostvaccinationwiththeseconddoseofbnt162b2vaccinealongitudinalobservationalcohortstudyinwesterngreece AT anastasiaparthymou factorsassociatedwithantisarscov2antibodytitres3monthspostvaccinationwiththeseconddoseofbnt162b2vaccinealongitudinalobservationalcohortstudyinwesterngreece AT evageliaehabeos factorsassociatedwithantisarscov2antibodytitres3monthspostvaccinationwiththeseconddoseofbnt162b2vaccinealongitudinalobservationalcohortstudyinwesterngreece AT georgeihabeos factorsassociatedwithantisarscov2antibodytitres3monthspostvaccinationwiththeseconddoseofbnt162b2vaccinealongitudinalobservationalcohortstudyinwesterngreece AT apostolosdeligakis factorsassociatedwithantisarscov2antibodytitres3monthspostvaccinationwiththeseconddoseofbnt162b2vaccinealongitudinalobservationalcohortstudyinwesterngreece AT ektoraslivieratos factorsassociatedwithantisarscov2antibodytitres3monthspostvaccinationwiththeseconddoseofbnt162b2vaccinealongitudinalobservationalcohortstudyinwesterngreece AT dionysiosvchartoumpekis factorsassociatedwithantisarscov2antibodytitres3monthspostvaccinationwiththeseconddoseofbnt162b2vaccinealongitudinalobservationalcohortstudyinwesterngreece |